Safety and Efficacy of Total-Dose Infusion of Low Molecular Weight Iron Dextran for Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease

[1]  P. Kalra,et al.  Comparison of intravenous iron sucrose versus low-molecular-weight iron dextran in chronic kidney disease. , 2009, Journal of renal care.

[2]  S. Bhandari,et al.  Improving efficiency and value in health care. Intravenous iron management for anaemia associated with chronic kidney disease: linking treatment to an outpatient clinic, optimizing service provision and patient choice. , 2008, Journal of evaluation in clinical practice.

[3]  Ajay K. Singh,et al.  Safety of ferumoxytol in patients with anemia and CKD. , 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[4]  R. Ayub,et al.  Efficacy and safety of total dose infusion of low molecular weight iron dextran in the treatment of iron deficiency anemia during pregnancy. , 2008, Journal of the College of Physicians and Surgeons--Pakistan : JCPSP.

[5]  G. D'Haens,et al.  A Novel Intravenous Iron Formulation for Treatment of Anemia in Inflammatory Bowel Disease: The Ferric Carboxymaltose (FERINJECT®) Randomized Controlled Trial , 2008, The American Journal of Gastroenterology.

[6]  G. Wall,et al.  Evaluation of total-dose iron sucrose infusions in patients with iron deficiency anemia. , 2008, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[7]  A. Berstad,et al.  Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases. , 2007, Inflammatory bowel diseases.

[8]  S. Kathula,et al.  Safety and efficacy of total dose infusion of iron dextran in iron deficiency anaemia , 2007, International journal of clinical practice.

[9]  I. Koutroubakis,et al.  Stimulating erythropoiesis in inflammatory bowel disease associated anemia. , 2007, World journal of gastroenterology.

[10]  J. Glaspy,et al.  Clinical update: intravenous iron for anaemia , 2007, The Lancet.

[11]  T. Menné,et al.  Inflammatory bowel disease in relation to contact allergy: A patient-based study , 2007, Scandinavian journal of gastroenterology.

[12]  C. Gasche,et al.  Systematic review: managing anaemia in Crohn's disease , 2006, Alimentary pharmacology & therapeutics.

[13]  J. Hollands,et al.  Safety of high-dose iron sucrose infusion in hospitalized patients with chronic kidney disease. , 2006, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[14]  E. Kouroumalis,et al.  Effectiveness of darbepoetin-alfa in combination with intravenous iron sucrose in patients with inflammatory bowel disease and refractory anaemia: a pilot study , 2006, European journal of gastroenterology & hepatology.

[15]  S. Schreiber,et al.  Intravenous Iron Sucrose versus Oral Iron Supplementation for the Treatment of Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease—A Randomized, Controlled, Open-Label, Multicenter Study , 2005, The American Journal of Gastroenterology.

[16]  T. Hausken,et al.  Oral ferrous fumarate or intravenous iron sucrose for patients with inflammatory bowel disease , 2005, Scandinavian journal of gastroenterology.

[17]  I. Cavill,et al.  Iron, anaemia, and inflammatory bowel diseases , 2004, Gut.

[18]  G. Chertow,et al.  On the relative safety of parenteral iron formulations. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[19]  J. Ofman,et al.  Prevalence and outcomes of anemia in inflammatory bowel disease: a systematic review of the literature. , 2004, The American journal of medicine.

[20]  M. H. Schwenk,et al.  The safety and efficacy of an accelerated iron sucrose dosing regimen in patients with chronic kidney disease. , 2003, Kidney international. Supplement.

[21]  R. Baldassano,et al.  Total dose intravenous infusion of iron dextran for iron-deficiency anemia in children with inflammatory bowel disease. , 2002, Journal of pediatric gastroenterology and nutrition.

[22]  S. K. Agarwal,et al.  TOTAL DOSE INFUSION IRON DEXTRAN THERAPY IN PREDIALYSIS CHRONIC RENAL FAILURE PATIENTS , 2002, Renal failure.

[23]  W. Petritsch,et al.  Prediction of response to iron sucrose in inflammatory bowel disease-associated anemia , 2001, American Journal of Gastroenterology.

[24]  F. D'armiento,et al.  Allergy and Mucosal Eosinophil Infiltrate in Ulcerative Colitis , 2000, Scandinavian journal of gastroenterology.

[25]  R. Pounder,et al.  A simple clinical colitis activity index , 1998, Gut.

[26]  F Kern,et al.  Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. , 1976, Gastroenterology.

[27]  Ganzoni Am,et al.  [Intravenous iron-dextran: therapeutic and experimental possibilities]. , 1970, Schweizerische medizinische Wochenschrift.

[28]  G. Bodemar,et al.  Treatment of anaemia in inflammatory bowel disease with iron sucrose. , 2004, Scandinavian journal of gastroenterology.

[29]  J. Winchester,et al.  A randomized trial of three iron dextran infusion methods for anemia in EPO-treated dialysis patients. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[30]  J. Lennard-jones,et al.  Classification of inflammatory bowel disease. , 1989, Scandinavian journal of gastroenterology. Supplement.